1mg retatrutide (Reta GLP-3) - 99%+ Purity Retatrutide 10mg GLP-1 99% Purity

2023: Lawsuits are filed against Novo Nordisk on behalf of patients who took the drugs and developed gastroparesis/stomach paralysis problems Pop Culture Weight Loss Phenomenon Is Paralyzing Peoples Stomachs FDA, Scientific Studies and Literature on Ozempic, Wegovy, and Rybelsus Gastroparesis/Stomach Paralysis The below studies constitute a small sampling of the scientific literature and studies published on the diabetes weight-loss drugs and gastroparesis/stomach paralysis: Jensterle et al (2023) : Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity This was a small clinical trial of 20 obese female patients with polycystic ovary syndrome who were given semaglutide or placebo

Ensure sufficient protein intake through lean meats, poultry, fish, beans, and lentils

A dangerous drug interaction could occur

The manufacturer, Eli Lilly, is enrolling patients with type 2 diabetes to compare the effect of retatrutide with semaglutide in adult patients with type 2 diabetes and poor glycemic control with metformin and with or without SGLT2 inhibitors

,

Most patients describe it as virtually painless and easy to do once a week